Dougherty & Co Initiates Coverage on Catasys (NASDAQ:CATS)

Dougherty & Co began coverage on shares of Catasys (NASDAQ:CATS) in a research note published on Tuesday, May 7th, FlyOnTheWall reports. The brokerage issued a buy rating on the stock.

CATS has been the topic of a number of other research reports. Zacks Investment Research cut Catasys from a strong-buy rating to a hold rating in a report on Monday, February 11th. TheStreet upgraded Catasys from a d+ rating to a c rating in a report on Tuesday, January 29th. started coverage on Catasys in a report on Wednesday, February 13th. They set an outperform rating and a $16.00 target price on the stock. ValuEngine cut Catasys from a strong-buy rating to a buy rating in a report on Monday, February 4th. Finally, began coverage on Catasys in a report on Wednesday, February 13th. They set an outperform rating and a $16.00 price objective on the stock. One analyst has rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Catasys has an average rating of Buy and an average price target of $17.40.

CATS traded down $1.01 on Tuesday, hitting $17.39. 158,764 shares of the company traded hands, compared to its average volume of 131,280. The company has a market cap of $281.98 million, a PE ratio of -19.54 and a beta of 2.07. Catasys has a 12-month low of $6.24 and a 12-month high of $20.83.

Catasys (NASDAQ:CATS) last issued its earnings results on Thursday, May 9th. The company reported ($0.18) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.06. The business had revenue of $6.81 million for the quarter, compared to analysts’ expectations of $5.64 million. Analysts predict that Catasys will post -0.96 earnings per share for the current fiscal year.

In other Catasys news, major shareholder David E. Smith sold 43,037 shares of the firm’s stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $13.86, for a total value of $596,492.82. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, major shareholder David E. Smith sold 7,643 shares of the firm’s stock in a transaction dated Friday, March 22nd. The shares were sold at an average price of $13.95, for a total value of $106,619.85. The disclosure for this sale can be found here. Insiders sold a total of 532,355 shares of company stock worth $8,298,358 over the last ninety days. Corporate insiders own 73.80% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in CATS. JPMorgan Chase & Co. boosted its stake in Catasys by 205.5% in the third quarter. JPMorgan Chase & Co. now owns 10,418 shares of the company’s stock valued at $134,000 after acquiring an additional 7,008 shares during the period. Janney Montgomery Scott LLC raised its holdings in shares of Catasys by 9.7% during the fourth quarter. Janney Montgomery Scott LLC now owns 143,756 shares of the company’s stock valued at $1,347,000 after buying an additional 12,742 shares during the last quarter. Westwood Management Corp IL raised its holdings in shares of Catasys by 33.3% during the fourth quarter. Westwood Management Corp IL now owns 40,000 shares of the company’s stock valued at $375,000 after buying an additional 10,000 shares during the last quarter. Vanguard Group Inc raised its holdings in shares of Catasys by 53.8% during the third quarter. Vanguard Group Inc now owns 171,813 shares of the company’s stock valued at $2,208,000 after buying an additional 60,090 shares during the last quarter. Finally, Vanguard Group Inc. raised its holdings in shares of Catasys by 53.8% during the third quarter. Vanguard Group Inc. now owns 171,813 shares of the company’s stock valued at $2,208,000 after buying an additional 60,090 shares during the last quarter. 13.55% of the stock is currently owned by institutional investors and hedge funds.

About Catasys

Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.

Featured Story: Fundamental Analysis – How It Helps Investors

Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply